Laryngeal Cancer

Laryngeal cancer is a disease in which malignant cells form in the tissues of the larynx, the part of the throat between the base of the tongue and the trachea. The larynx contains the vocal cords.

Most laryngeal cancers form in squamous cells, the thin, flat cells that line the inside of the larynx.

According to the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program, it was estimated that 13,020 people would be diagnosed with laryngeal cancer and some 3,910 people would die of the disease in the United States in 2025. The five-year relative survival rate is estimated to be around 62%.

Laryngeal cancer is a type of head and neck cancer. Overall, head and neck cancers account for about 3.5% of all cancers in the United States. SEER estimated that about 72,680 cases of head and neck cancer would be diagnosed in the United States in 2025, and about 16,680 people would die from these diseases.

The use of tobacco products and drinking too much alcohol can increase the risk for laryngeal cancer.

Laryngeal Cancer Treatment (Adult) (PDQ®)

Source: National Cancer Institute